Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million). Founded in 1978, Bartels is a world leader in the development and manufacture of diagnostic products for the identification of infectious agents which are cell dependent.
Trinity Biotech buys Bartels
Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million)
Join The Irish Times on WhatsApp and stay up to date
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
Listen to Inside Business podcast for a look at business and economics from an Irish perspective